RECOMBINANT WEST NILE VIRUS VACCINE ADJUVANTED WITH SLA-LSQ
$2,997,218
| Recipient | HAWAII BIOTECH, INC. UEI ECJKEEFL4L51 |
|---|---|
| Award ID | 75N93022C00034 |
| Award amount | $2,997,218 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN12 |
| Start date | Jul 5, 2022 |
| End date | Jul 5, 2025 |
| Place of performance | HONOLULU, HI |
| Record updated | Aug 3, 2022 |
View the official award record
More awards won by HAWAII BIOTECH, INC.
IGF::OT::IGF - "DEVELOPMENT OF A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS."
Department of Health and Human Services · $24,099,174 · Sep 20, 2018
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids